Aspiriant LLC’s Lam Research LRCX Stock Holding History

Aspiriant LLC’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.02M	Buy	3,098 +27	+0.9%	+$8.43K	0.02%	169
2026 Q2	$1.33M	Buy	3,071 +1,730	+129%	+$525K	0.03%	152
2026 Q1	$287K	Sell	1,341 -126	-9%	-$28.2K	0.01%	286
2025 Q4	$251K	Buy	+1,467	New	+$228K	0.01%	296
2024 Q2	–	Sell	-2,280	Closed	-$222K	–	313
2024 Q1	$222K	Buy	+2,280	New	+$201K	0.01%	297
2023 Q4	–	Sell	-3,810	Closed	-$239K	–	312
2023 Q3	$239K	Buy	+3,810	New	+$250K	0.01%	251

Other funds holding LRCX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Aspiriant LLC's LRCX Position: Q3 2026 in Review

Aspiriant LLC increased its Lam Research (LRCX) stake by 0.88% in Q3 2026, buying an estimated $8.43K and bringing the position to 3,098 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #169.

Aspiriant LLC first reported a position in LRCX in Q3 2023 and has held it in 6 quarters since. The position peaked at $1.33M in Q2 2026. 1,109 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

Aspiriant LLC held 3,098 shares of Lam Research worth $1.02M as of Q3 2026.
Aspiriant LLC bought 27 Lam Research shares in Q3 2026, an estimated $8.43K.
Lam Research made up 0.02% of Aspiriant LLC's portfolio in Q3 2026, its #169 holding.
Aspiriant LLC first reported a position in Lam Research in Q3 2023 and has held it in 6 quarters since.
Aspiriant LLC's Lam Research position peaked at $1.33M in Q2 2026.
1,109 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.